Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Conference Call Minutes
Altamira Therapeutics, Ltd.NASDAQ: Saito) Q2 2024 Earnings Conference Call September 24, 2024 at 8:30 a.m. ET
Company Participants
Thomas Meyer – Founder, Chairman and CEO
Covadonga Paneda – Chief Operating Officer (COO)
Conference Call Participants
Hunter Diamond – Diamond Equity
operator
Hello and welcome to the Altamira Therapeutics 1H 2024 and Business Update Conference Call. Today’s call features Thomas Meyer, Founder, Chairman and CEO of Altamira, and Covadonga Paneda, Chief Operating Officer of Altamira.
Earlier today, Altamira issued a press release containing its financial results for the first half of 2024 and a comprehensive business update. This press release is available on the company’s website at www.altamiratherapeutics.com and has been filed with the SEC.
In today’s conference call, the Company will make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding future operating, financial or business performance or the Company’s strategies or expectations.
Forward-looking statements are based on management’s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results and business decisions to differ materially from those expressed in such statements.
These risks and uncertainties include, but are not limited to, the timing and conduct of our clinical trials, the clinical uniformity of our product candidates, the timing or likelihood of regulatory filings and approvals, our intellectual property status and financial position, and those described in the Risk Factors section of our Annual Report on Form 20-F and future filings with the Securities and Exchange Commission.
In addition, all forward-looking statements represent only the Company’s views as of the date hereof and should not be relied upon as representing views as of any subsequent date. The Company may elect to update these forward-looking statements at any time in the future, but specifically disclaims any obligation to do so.
